The glutathione transferase Mu null genotype leads to lower 6-MMPR levels in patients treated with azathioprine but not with mercaptopurine

Fulltext:
189861.pdf
Embargo:
until further notice
Size:
277.7Kb
Format:
PDF
Description:
Publisher’s version
Publication year
2018Source
Pharmacogenomics Journal, 18, 1, (2018), pp. 160-166ISSN
Publication type
Article / Letter to editor

Display more detailsDisplay less details
Organization
Gastroenterology
Haematology
Health Evidence
Human Genetics
Journal title
Pharmacogenomics Journal
Volume
vol. 18
Issue
iss. 1
Page start
p. 160
Page end
p. 166
Subject
All institutes and research themes of the Radboud University Medical Center; Radboudumc 0: Other Research RIMLS: Radboud Institute for Molecular Life Sciences; Radboudumc 11: Renal disorders RIMLS: Radboud Institute for Molecular Life Sciences; Radboudumc 17: Women's cancers RIHS: Radboud Institute for Health Sciences; Radboudumc 2: Cancer development and immune defence RIMLS: Radboud Institute for Molecular Life Sciences; Radboudumc 3: Disorders of movement DCMN: Donders Center for Medical Neuroscience; Radboudumc 4: lnfectious Diseases and Global Health RIHS: Radboud Institute for Health Sciences; Radboudumc 5: Inflammatory diseases RIHS: Radboud Institute for Health SciencesThis item appears in the following Collection(s)
- Academic publications [227248]
- Electronic publications [108577]
- Faculty of Medical Sciences [86732]
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.